Stockreport

Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... [Yahoo! Finance]

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF License, Collaboration, and Other Revenue: $1.8 million in Q3 2024, compared to $1.9 million in Q3 2023. Cost of Goods Sold: $14.2 million in Q3 2024, down from $18 m [Read more]